Cracking the Code of Human Diseases Using Next-Generation Sequencing: Applications, Challenges, and Perspectives

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Precone, Vincenza ^a,b   Del Monaco, Valentina ^a,b   Esposito, Maria Valeria ^a   De Palma, Fatima Domenica Elisa ^a,b   Ruocco, Anna ^a,b   Salvatore, Francesco ^a,b,c   D'Argenio, Valeria ^a,b  

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c IRCCS SDN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT;

3' UNTRANSLATED REGION; CIRCULATING TUMOR CELL; COPY NUMBER VARIATION; DISEASES; DNA METHYLATION; DNA SEQUENCE; GENE EXPRESSION REGULATION; HUMAN; HUMAN GENOME; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; MEDICAL ETHICS; METAGENOMICS; MOLECULAR DIAGNOSTICS; MULTIPLEX POLYMERASE CHAIN REACTION; NEXT GENERATION SEQUENCING; PHARMACOGENOMICS; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; REVIEW; GENETIC DATABASE; GENETIC DISORDER; GENETICS; GENOMICS; HIGH THROUGHPUT SEQUENCING; MUTATION; PATHOLOGY; PROCEDURES;

DATABASES, GENETIC; DNA METHYLATION; GENETIC DISEASES, INBORN; GENOME, HUMAN; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION;

EID: 84948807599     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/161648     Document Type: Review

References (182)

1. F. Sanger, S. Nicklen, and A. R. Coulson, "DNA sequencing with chain-terminating inhibitors," Proceedings of the National Academy of Sciences of the United States of America, vol. 74, no. 12, pp. 5463-5467, 1977.
2. J. C. Venter, M. D. Adams, E. W. Myers et al., "The sequence of the human genome," Science, vol. 291, no. 5507, pp. 1304-1351, 2001.
3. International Human Genome Sequencing Consortium, "Finishing the euchromatic sequence of the human genome," Nature, vol. 431, no. 7011, pp. 931-945, 2004.
4. E. R. Mardis, "The impact of next-generation sequencing technology on genetics," Trends in Genetics, vol. 24, no. 3, pp. 133-141, 2008.
5. A. von Bubnoff, "Next-generation sequencing: the race is on," Cell, vol. 132, no. 5, pp. 721-723, 2008.
6. J. Reuter, D. V. Spacek, and M. Snyder, "High-throughput sequencing technologies,"Molecular Cell, vol. 58,no. 4, pp. 586-597, 2015.
7. R. R. Gullapalli, K. V. Desai, L. Santana-Santos, J. A. Kant, and M. J. Becich, "Next generation sequencing in clinical medicine: challenges and lessons for pathology and biomedical informatics," Journal of Pathology Informatics, vol. 3, article 40, 2012.
8. R. K. Thomas, E. Nickerson, J. F. Simons et al., "Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing," Nature Medicine, vol. 12, no. 7, pp. 852-855, 2006.
9. T. J. Albert, M. N. Molla, D. M. Muzny et al., "Direct selection of human genomic loci by microarray hybridization," Nature Methods, vol. 4, no. 11, pp. 903-905, 2007.
10. E. H. Turner, C. Lee, S. B. Ng, D. A. Nickerson, and J. Shendure, "Massively parallel exon capture and library-free resequencing across 16 genomes," Nature Methods, vol. 6, no. 5, pp. 315-316, 2009.
11. M. P. Ball, J. Billy Li, Y. Gao et al., "Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells," Nature Biotechnology, vol. 27, no. 4, pp. 361-368, 2009.
12. Human Microbiome Project Consortium, "Structure, function and diversity of the healthy human microbiome," Nature, vol. 486, no. 7402, pp. 207-214, 2012.
13. J. R. ten Bosch and W. W. Grody, "Keeping up with the next generation: massively parallel sequencing in clinical diagnostics," Journal of Molecular Diagnostics, vol. 10, no. 6, pp. 484-492, 2008.
14. J. Zhang, R. Chiodini, A. Badr, and G. Zhang, "The impact of next-generation sequencing on genomics," Journal of Genetics and Genomics, vol. 38, no. 3, pp. 95-109, 2011.
15. A. M. Smith, L. E. Heisler, R. P. St. Onge et al., "Highlymultiplexed barcode sequencing: an efficient method for parallel analysis of pooled samples," Nucleic Acids Research, vol. 38, article e142, Article ID gkq368, 2010.
16. M. Yeager, N. Xiao, R. B. Hayes et al., "Comprehensive resequence analysis of a 136 kb region of human chromosome 8q24 associated with prostate and colon cancers," Human Genetics, vol. 124, no. 2, pp. 161-170, 2008.
17. S. Hollants, E. J. W. Redeker, and G. Matthijs, "Microfluidic amplification as a tool for massive parallel sequencing of the familial hypercholesterolemia genes," Clinical Chemistry, vol. 58, no. 4, pp. 717-724, 2012.
18. R. Tewhey, J. B. Warner, M. Nakano et al., "Microdroplet-based PCR enrichment for large-scale targeted sequencing," Nature Biotechnology, vol. 27, no. 11, pp. 1025-1031, 2009.
19. R. J. P. Bonnal, M. Severgnini, A. Castaldi et al., "Reliable resequencing of the human dystrophin locus by universal long polymerase chain reaction and massive pyrosequencing," Analytical Biochemistry, vol. 406, no. 2, pp. 176-184, 2010.
20. I. Hernan, E. Borrs, M. de Sousa Dias et al., "Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing," Journal of Molecular Diagnostics, vol. 14, no. 3, pp. 286-293, 2012.
21. V. Morinière, K. Dahan, P. Hilbert et al., "Improving mutation screening in familial hematuric nephropathies through next generation sequencing," Journal of the American Society of Nephrology, vol. 25, no. 12, pp. 2740-2751, 2014.
22. A. Kohlmann, V. Grossmann, N. Nadarajah, and T. Haferlach, "Next-generation sequencing-feasibility and practicality in haematology," British Journal ofHaematology, vol. 160, no. 6,pp. 736-753, 2013.
23. C. Y. Ok, K. P. Patel, G. Garcia-Manero et al., "Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases," Leukemia Research, vol. 39, no. 3, pp. 348-354, 2015.
24. D. Trujillano, M. D. Ramos, J. González et al., "Next generation diagnostics of cystic fibrosis and CFTR-related disorders by targeted multiplex high-coverage resequencing of CFTR," Journal of Medical Genetics, vol. 50, no. 7, pp. 455-462, 2013.
25. A. N. Abou Tayoun, C. D. Tunkey, T. J. Pugh et al., "A comprehensive assay for CFTR mutational analysis using nextgeneration sequencing.," Clinical Chemistry, vol. 59, no. 10, pp. 1481-1488, 2013.
26. F. Chang and M. M. Li, "Clinical application of amplicon-based next-generation sequencing in cancer," Cancer Genetics, vol. 206, no. 12, pp. 413-419, 2013.
27. L. Beltrame, M. Di Marino, R. Fruscio et al., "Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study," Annals of Oncology, vol. 26, no. 7, pp. 1363-1371, 2015.
28. M. F. Hansen, U. Neckmann, L. A. Lavik et al., "A massive parallel sequencing workflow for diagnostic genetic testing of mismatch repair genes," Molecular Genetics & Genomic Medicine, vol. 2, no. 2, pp. 186-200, 2014.
29. C. Desmedt, T. Voet, C. Sotiriou, and P. J. Campbell, "Nextgeneration sequencing in breast cancer: first take home messages," Current Opinion in Oncology, vol. 24, no. 6, pp. 597-604, 2012.
30. F. Vaca-Paniagua, R. M. Alvarez-Gomez, V. Fragoso-Ontiveros et al., "Full-exon pyrosequencing screening of BRCA germline mutations inMexican women with inherited breast and ovarian cancer," PLoS ONE, vol. 7, no. 5,Article ID e37432, 2012.
31. F. Pern, N. Bogdanova, P. Schürmann et al., "Mutation analysis of BRCA1, BRCA2, PALB2 and BRD7 in a hospital-based series of German patients with triple-negative breast cancer," PLoS ONE, vol. 7, no. 10, Article IDe47993, 2012
32. L. Balabanski, G. Antov, I. Dimova et al., "Next-generation sequencing of BRCA1 and BRCA2 in breast cancer patients and control subjects," Molecular and Clinical Oncology, vol. 2, no. 3, pp. 435-439, 2014.
33. V. D'Argenio, M. V. Esposito, A. Telese et al., "The molecular analysis of BRCA1 and BRCA2: next-generation sequencing supersedes conventional approaches," Clinica ChimicaActa, vol. 446, pp. 221-225, 2015.
34. D. Sie, P. J. F. Snijders, G. A. Meijer et al., "Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology," Cellular Oncology, vol. 37, no. 5, pp. 353-361, 2014.
35. P. Concolino, A. Costella, A. Minucci et al., "A preliminary Quality Control (QC) for next generation sequencing (NGS) library evaluation turns out to be a very useful tool for a rapid detection of BRCA1/2 deleterious mutations," Clinica Chimica Acta, vol. 437, pp. 72-77, 2014.
36. A. ElSharawy, J. Warner, J. Olson et al., "Accurate variant detection across non-amplified and whole genome amplified DNA using targeted next generation sequencing," BMC Genomics, vol. 13, article 500, 2012.
37. C. A. Valencia,D. Rhodenizer, S. Bhide et al., "Assessment of target enrichment platforms using massively parallel sequencing for the mutation detection for congenital muscular dystrophy," Journal of Molecular Diagnostics, vol. 14, no. 3, pp. 233-246, 2012.
38. D. S. Paul, P. Guilhamon, A. Karpathakis et al., "Assessment of raindrop BS-seq as a method for large-scale, targeted bisulfite sequencing," Epigenetics, vol. 9, no. 5, pp. 678-684, 2014.
39. C. M. Watson, L. A. Crinnion, J. E. Morgan et al., "Robust diagnostic genetic testing using solution capture enrichment and a novel variant-filtering interface," Human Mutation, vol. 35, no. 4, pp. 434-441, 2014.
40. E. Hodges, Z. Xuan, V. Balija et al., "Genome-wide in situ exon capture for selective resequencing," Nature Genetics, vol. 39, no. 12, pp. 1522-1527, 2007.
41. A. Gnirke, A. Melnikov, J. Maguire et al., "Solution hybrid selection with ultra-long oligonucleotides formassively parallel targeted sequencing," Nature Biotechnology, vol. 27, no. 2, pp. 182-189, 2009.
42. Z.-J. Liu, H.-F. Li, G.-H. Tan et al., "Identify mutation in amyotrophic lateral sclerosis cases using HaloPlex target enrichment system," Neurobiology of Aging, vol. 35,no. 12,pp. 2881e11-2881e15, 2014.
43. E. Schaefer, P. Helms, L. Marcellin et al., "Next-generation sequencing (NGS) as a fast molecular diagnosis tool for left ventricular noncompaction in an infant with compoundmutations in the MYBPC3 gene," European Journal of Medical Genetics, vol. 57, no. 4, pp. 129-132, 2014.
44. The 1000 Genomes Project Consortium, G. R. Abecasis, D. Altshuler et al., "A map of human genome variation from population-scale sequencing," Nature, vol. 467, no. 7319, pp. 1061-1073, 2010.
45. W. Fu, T. D. O'Connor,G. Jun et al., "NHLBIExome Sequencing Project, Akey JM. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants," Nature, vol. 493, no. 7431, pp. 216-220, 2013.
46. J. Majewski, J. Schwartzentruber, E. Lalonde, A. Montpetit, and N. Jabado, "What can exome sequencing do for you" Journal of Medical Genetics, vol. 48, no. 9, pp. 580-589, 2011.
47. S. B. Ng, K. J. Buckingham, C. Lee et al., "Exome sequencing identifies the cause of a mendelian disorder," Nature Genetics, vol. 42, no. 1, pp. 30-35, 2010.
48. J. K. Teer and J. C. Mullikin, "Exome sequencing: the sweet spot before whole genomes," Human Molecular Genetics, vol. 19, no. 2, pp. R145-R151, 2010.
49. M. J. Clark, R. Chen, and M. Snyder, "Exome sequencing by targeted enrichment," Current Protocols in Molecular Biology, chapter 7:unit 7. 12, 2013.
50. Asan, Y. Xu,H. Jiang et al., "Comprehensive comparisonof three commercial human whole-exome capture platforms," Genome Biology, vol. 12, article R95, 2011.
51. K. Bodi, A. G. Perera, P. S. Adams et al., "Comparison of commercially available target enrichment methods for nextgeneration sequencing," Journal of Biomolecular Techniques, vol. 24, no. 2, pp. 73-86, 2013.
52. A. Warr, C. Robert, D. Hume, A. Archibald, N. Deeb, and M. Watson, "Exome sequencing: current and future perspectives," G3 (Bethesda), vol. 5, pp. 1543-1550, 2015.
53. T. Walsh, H. Shahin, T. Elkan-Miller et al., "Whole exome sequencing and homozygosity mapping identify mutation in the cell polarity protein GPSM2 as the cause of nonsyndromic hearing loss DFNB82," American Journal of Human Genetics, vol. 87, no. 1, pp. 90-94, 2010.
54. A. Sirmaci, T. Walsh, H. Akay et al., "MASP1 mutations in patients with facial, umbilical, coccygeal, and auditory findings of carnevale, malpuech, OSA, and michels syndromes," The AmericanJournal of HumanGenetics, vol. 87,no. 5, pp. 679-686, 2010.
55. O. Diaz-Horta, D. Duman, J. Foster II et al., "Whole-exome sequencing efficiently detects rare mutations in autosomal recessive nonsyndromic hearing loss," PLoS ONE, vol. 7, no. 11, Article ID e50628, 2012.
56. H.-M. Woo, H.-J. Park, M.-H. Park et al., "Identification of CDH23 mutations in Korean families with hearing loss by whole-exome sequencing," BMC Medical Genetics, vol. 15, article 46, 2014.
57. G. Girotto, K. Abdulhadi, A. Buniello et al., "Linkage study and exome sequencing identify a BDP1 mutation associated with hereditary hearing loss," PLoS ONE, vol. 8, no. 12, Article ID e80323, 2013.
58. A. Bonnefond, E. Durand, O. Sand et al., "Molecular diagnosis of neonatal diabetes mellitus using next-generation sequencing of the whole exome," PLoS ONE, vol. 5, no. 10, Article IDe13630, 2010.
59. S. Hillman, M. Smart, C. Bacchelli, L. Ocaka, andD. J. Williams, "2. 4 whole exome sequencing of growth restricted offspring identifies gene variants implicated inmaturity onset diabetes of the young,"Archives ofDisease inChildhood: Fetal andNeonatal Edition, vol. 99, article A2, 2014.
60. M. Cąlişkan, J. X. Chong, L. Uricchio et al., "Exome sequencing reveals a novel mutation for autosomal recessive nonsyndromic mental retardation in the TECR gene on chromosome 19p13," Human Molecular Genetics, vol. 20, no. 7, Article ID ddq569, pp. 1285-1289, 2011.
61. C. E. Prada, C. Gonzaga-Jauregui, R. Tannenbaum et al., "Clinical utility of whole-exome sequencing in rare diseases: galactosialidosis," European Journal of MedicalGenetics, vol. 57, no. 7, pp. 339-344, 2014.
62. A. Iglesias, K. Anyane-Yeboa, J. Wynn et al., "The usefulness of whole-exome sequencing in routine clinical practice," Genetics in Medicine, vol. 16, no. 12, pp. 922-931, 2014.
63. M. Choi, U. I. Scholl, W. Ji et al., "Genetic diagnosis by whole exome capture and massively parallel DNA sequencing," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 45, pp. 19096-19101, 2009.
64. R. W. K. Chiu, K. C. A. Chan, Y. Gao et al., "Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing ofDNAinmaternal plasma," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 51, pp. 20458-20463, 2008.
65. A. J. Sehnert, B. Rhees, D. Comstock et al., "Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetalDNAfrommaternal blood," Clinical Chemistry, vol. 57, no. 7, pp. 1042-1049, 2011.
66. E. Z. Chen, R. W. K. Chiu, H. Sun et al., "Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 bymaternal plasma DNA sequencing," PLoS ONE, vol. 6, no. 7, Article ID e21791, 2011.
67. D. W. Bianchi, R. Lamar Parker, J. Wentworth et al., "DNA sequencing versus standard prenatal aneuploidy screening,"The New England Journal of Medicine, vol. 370, no. 9, pp. 799-808, 2014.
68. Y. Song, C. Liu, H. Qi, Y. Zhang, X. Bian, and J. Liu, "Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population," Prenatal Diagnosis, vol. 33, no. 7, pp. 700-706, 2013.
69. M. M. Gil, M. S. Quezada, B. Bregant, M. Ferraro, and K. H. Nicolaides, "Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies," Ultrasound in Obstetrics and Gynecology, vol. 42, no. 1, pp. 34-40, 2013.
70. D. W. Bianchi, L. D. Platt, J. D. Goldberg, A. Z. Abuhamad, A. J. Sehnert, and R. P. Rava, "Genome-wide fetal aneuploidy detection bymaternal plasma DNA sequencing," Obstetrics and Gynecology, vol. 119, no. 5, pp. 890-901, 2012.
71. H. Yamamoto, Y. Watanabe, T. Maehata et al., "An updated review of gastric cancer in the next-generation sequencing era: insights frombench to bedside and vice versa," World Journal of Gastroenterology, vol. 20, no. 14, pp. 3927-3937, 2014.
72. K. Wang, J. Kan, S. T. Yuen et al., "Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer," Nature Genetics, vol. 43, no. 12, pp. 1219-1223, 2011.
73. N. F. C. C. de Miranda, K. Georgiou, L. Chen et al., "Exome sequencing reveals novelmutation targets in diffuse large B-cell lymphomas derived from Chinese patients," Blood, vol. 124, no. 16, pp. 2544-2553, 2014.
74. I. Vater, M. Montesinos-Rongen, M. Schlesner et al., "The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing," Leukemia, 2014.
75. K. Snape, E. Ruark, P. Tarpey et al., "Predisposition gene identification in common cancers by exome sequencing: insights from familial breast cancer," Breast Cancer Research and Treatment, vol. 134, no. 1, pp. 429-433, 2012.
76. H. Shi, G. Moriceau, X. Kong et al., "Melanoma whole-exome sequencing identifies 600B-RAF amplification-mediated acquired B-RAF inhibitor resistance," Nature Communications, vol. 3, article 724, 2012.
77. M. Kunz, M. Dannemann, and J. Kelso, "High-throughput sequencing of themelanoma genome," Experimental Dermatology, vol. 22, no. 1, pp. 10-17, 2013.
78. A. Kumar, T. A. White, A. P. MacKenzie et al., "Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers," Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 41, pp. 17087-17092, 2011.
79. J. Lindberg, D. Klevebring,W. Liu et al., "Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins," European Urology, vol. 63, no. 2, pp. 347-353, 2013.
80. J. G. Lohr, V. A. Adalsteinsson, K. Cibulskis et al., "Wholeexome sequencing of circulating tumor cells provides a window into metastatic prostate cancer," Nature Biotechnology, vol. 32, no. 5, pp. 479-484, 2014.
81. A. Wesolowska, M. D. Dalgaard, L. Borst et al., "Cost-effective multiplexing before capture allows screening of 25 000 clinically relevant SNPs in childhood acute lymphoblastic leukemia," Leukemia, vol. 25, no. 6, pp. 1001-1006, 2011.
82. R. Daneshjou, E. R. Gamazon, B. Burkley et al., "Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans," Blood, vol. 124, no. 14, pp. 2298-2305, 2014.
83. M. Apellániz-Ruiz, M.-Y. Lee, L. Sánchez-Barroso et al., "Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathy," Clinical Cancer Research, vol. 21, no. 2, pp. 322-328, 2015.
84. A. Patwardhan, J. Harris, N. Leng et al., "Achieving highsensitivity for clinical applications using augmented exome sequencing," Genome Medicine, vol. 7, article 71, 2015.
85. L. Mamanova, A. J. Coffey, C. E. Scott et al., "Target-enrichment strategies for next-generation sequencing,"NatureMethods, vol. 7, no. 2, pp. 111-118, 2010.
86. F. Mertes, A. ElSharawy, S. Sauer et al., "Targeted enrichment of genomic DNA regions for next-generation sequencing," Briefings in Functional Genomics, vol. 10, no. 6, pp. 374-386, 2011.
87. W. Li, J. Freudenberg, and P. Miramontes, "Diminishing return for increased Mappability with longer sequencing reads: implications of the k-mer distributions in the human genome," BMC Bioinformatics, vol. 15, article 2, 2014.
88. L.-S. Chou, C.-S. J. Liu, B. Boese, X. Zhang, and R. Mao, "DNA sequence capture and enrichment by microarray followed by next-generation sequencing for targeted resequencing: neurofibromatosis type 1 gene as a model," Clinical Chemistry, vol. 56, no. 1, pp. 62-72, 2010.
89. S. Dames, J. Durtschi, K. Geiersbach, J. Stephens, and K. V. Voelkerding, "Comparison of the illumina genome analyzer and roche 454 GS FLX for resequencing of hypertrophic cardiomyopathy-associated genes," Journal of Biomolecular Techniques, vol. 21, no. 2, pp. 73-80, 2010.
90. D. Shigemizu, Y. Momozawa, T. Abe et al., "Performance comparison of four commercial human whole-exome capture platforms," Scientific Reports, vol. 5, article 12742, 2015.
91. A. E. Shearer, A. P. DeLuca, M. S. Hildebrand et al., "Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 49, pp. 21104-21109, 2010.
92. Z. Brownstein, L. M. Friedman, H. Shahin et al., "Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in middle eastern families," Genome Biology, vol. 12, no. 9, article R89, 2011.
93. A. H. Németh, A. C. Kwasniewska, S. Lise et al., "Next generation sequencing for molecular diagnosis of neurological disorders using ataxias as a model," Brain, vol. 136, no. 10, pp. 3106-3118, 2013.
94. V. D'Argenio, G. Frisso, V. Precone et al., "DNA sequence capture and next-generation sequencing for the molecular diagnosis of genetic cardiomyopathies," Journal of Molecular Diagnostics, vol. 16, no. 1, pp. 32-44, 2014.
95. M. E. Shanks, S. M. Downes, R. R. Copley et al., "Nextgeneration sequencing (NGS) as a diagnostic tool for retinal degeneration reveals amuch higher detection rate in early-onset disease," European Journal of Human Genetics, vol. 21, no. 3, pp. 274-280, 2013.
96. I. J. Nijman, J. M. vanMontfrans,M. Hoogstraat et al., "Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies," Journal of Allergy and Clinical Immunology, vol. 133, no. 2, pp. 529-534, 2014.
97. G. D. Hariani, E. T. Lam, T. Havener et al., "Correction: application of next generation sequencing to CEPH cell lines to discover variants associated with FDA approved chemotherapeutics," BMC Research Notes, vol. 7, article 652, 2014.
98. D. B. Johnson, K. H. Dahlman, J. Knol et al., "Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel," Oncologist, vol. 19, no. 6, pp. 616-622, 2014.
99. J. S. Ross, K. Wang, J. V. Rand et al., "Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies," American Journal of Surgical Pathology, vol. 38, no. 2, pp. 235-238, 2014.
100. H. K. Chong, T. Wang, H.-M. Lu et al., "The validation and clinical implementation of BRCAplus: a comprehensive highrisk breast cancer diagnostic assay," PLoS ONE, vol. 9, no. 5, Article ID e97408, 2014.
101. G. J. W. Liao, K. C. A. Chan, P. Jiang et al., "Noninvasive prenatal diagnosis of fetal trisomy 21 by allelic ratio analysis using targetedmassively parallel sequencing of maternal plasma DNA," PLoS ONE, vol. 7, no. 5,Article ID e38154, 2012.
102. B. C. Lim, S. Lee, J.-Y. Shin et al., "Molecular diagnosis of congenitalmuscular dystrophies with defective glycosylation of alpha-dystroglycan using next-generation sequencing technology," Neuromuscular Disorders, vol. 23, no. 4, pp. 337-344, 2013.
103. M. Hinchcliffe, H. Le, A. Fimmel et al., "Diagnostic validation of a familial hypercholesterolaemia cohort provides a model for using targeted next generation DNA sequencing in the clinical setting," Pathology, vol. 46, no. 1, pp. 60-68, 2014.
104. L. Castéra, S. Krieger, A. Rousselin et al., "Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes," European Journal of Human Genetics, vol. 22, no. 11, pp. 1305-1313, 2014.
105. A. Fernández-Marmiesse, M. Morey, M. Pineda et al., "Assessment of a targeted resequencing assay as a support tool in the diagnosis of lysosomal storage disorders," Orphanet Journal of Rare Diseases, vol. 9, article 59, 2014.
106. W. Wooderchak-Donahue, C. VanSant-Webb, T. Tvrdik et al., "Clinical utility of a next generation sequencing panel assay for Marfan and Marfan-like syndromes featuring aortopathy," American Journal ofMedical Genetics A, vol. 167, no. 8, pp. 1747-1757, 2015.
107. S. Dames, L.-S. Chou, Y. Xiao et al., "The development of nextgeneration sequencing assays for the mitochondrial genome and 108 nuclear genes associated with mitochondrial disorders," Journal ofMolecularDiagnostics, vol. 15,no. 4, pp. 526-534,2013.
108. E. H. Kim, S. Lee, J. Park, K. Lee, J. Bhak, and B. C. Kim, "New lung cancer panel for high-throughput targeted resequencing," Genomics & Informatics, vol. 12, no. 2, pp. 50-57, 2014.
109. A. Cortes, J. Field, E. A. Glazov et al., "Resequencing and fine-mapping of the chromosome 12q13-14 locus associated with multiple sclerosis refines the number of implicated genes," Human Molecular Genetics, vol. 22, no. 11, pp. 2283-2292, 2013.
110. H. Stranneheim and A. Wedell, "Exome and genome sequencing: a revolution for the discovery and diagnosis of monogenic disorders," Journal of Internal Medicine, 2015.
111. B. Royer-Bertrand and C. Rivolta, "Whole genome sequencing as a means to assess pathogenic mutations in medical genetics and cancer," Cellular and Molecular Life Sciences, vol. 72, pp. 1463-1471, 2015.
112. A. Belkadi, A. Bolze, Y. Itan et al., "Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants," Proceedings of the National Academy of Sciences, vol. 112, no. 17, pp. 5473-5478, 2015.
113. T. Katsila and G. P. Patrinos, "Whole genome sequencing in pharmacogenomics," Frontiers in Pharmacology, vol. 6, article 61, 2015.
114. C. Mizzi, B. Peters, C. Mitropoulou et al., "Personalized pharmacogenomics profiling using whole-genome sequencing," Pharmacogenomics, vol. 15, no. 9, pp. 1223-1234, 2014.
115. M. Nagasaki, J. Yasuda, F. Katsuoka et al., "Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals," Nature Communications, vol. 6, article 8018, 2015.
116. C. Gilissen, J. Y. Hehir-Kwa, D. T. Thung et al., "Genome sequencing identifiesmajor causes of severe intellectual disability," Nature, vol. 511, no. 7509, pp. 344-347, 2014.
117. K. Yamaguchi, M. Komura, R. Yamaguchi et al., "Detection of APC mosaicism by next-generation sequencing in an FAP patient," Journal of Human Genetics, vol. 60, no. 5, pp. 227-231, 2015.
118. M. A. Lalli, B. M. Bettcher, M. L. Arcila et al., "Whole-genome sequencing suggests a chemokine gene cluster thatmodifies age at onset in familial Alzheimer's disease," Molecular Psychiatry, vol. 20, pp. 1294-1300, 2015.
119. T. Mikeska and J. M. Craig, "DNA methylation biomarkers: cancer and beyond," Genes, vol. 5, no. 3, pp. 821-864, 2014.
120. T. De Meyer, E. Mampaey, M. Vlemmix et al., "Quality evaluation of methyl binding domain based kits for enrichment DNAmethylation sequencing," PLoS ONE, vol. 8, no. 3, Article ID e59068, 2013.
121. H. G. Hernández, M. Y. Tse, S. C. Pang, H. Arboleda, and D. A. Forero, "Optimizing methodologies for PCR-based DNA methylation analysis," BioTechniques, vol. 55, no. 4, pp. 181-197, 2013.
122. A. L. Brunner, D. S. Johnson, W. K. Si et al., "Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver," Genome Research, vol. 19, no. 6, pp. 1044-1056, 2009.
123. T. A. Down, V. K. Rakyan, D. J. Turner et al., "A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis," Nature Biotechnology, vol. 26, no. 7, pp. 779-785, 2008.
124. D. Serre, B. H. Lee, and A. H. Ting, "MBD-isolated genome sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome," Nucleic Acids Research, vol. 38, no. 2, pp. 391-399, 2010.
125. O. Bogdanovíc, A. Fernández-Miñán, J. J. Tena, E. de la Calle-Mustienes, and J. L. Gómez-Skarmeta, "The developmental epigenomics toolbox: ChIP-seq andMethylCap-seq profiling of early zebrafish embryos," Methods, vol. 62, no. 3, pp. 207-215, 2013.
126. B. A. Rodriguez, D. Frankhouser, M. Murphy et al., "Methods for high-throughput MethylCap-Seq data analysis," BMC Genomics, vol. 13, supplement 6, article S14, 2012.
127. A. Meissner,A. Gnirke, G. W. Bell, B. Ramsahoye, E. S. Lander, and R. Jaenisch, "Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis," Nucleic Acids Research, vol. 33, no. 18, pp. 5868-5877, 2005.
128. R. Lister, R. C. O'Malley, J. Tonti-Filippini et al., "Highly integrated single-base resolution maps of the epigenome in Arabidopsis," Cell, vol. 133, no. 3, pp. 523-536, 2008.
129. M. J. Booth, M. R. Branco,G. Ficz et al., "Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at singlebase resolution," Science, vol. 336, no. 6083, pp. 934-937, 2012.
130. S. K. Stewart, T. J. Morris, P. Guilhamon et al., "oxBS-450K: a method for analysing hydroxymethylation using 450K Bead-Chips," Methods, vol. 72, pp. 9-15, 2015.
131. C. Stirzaker, P. C. Taberlay, A. L. Statham, and S. J. Clark, "Mining cancer methylomes: prospects and challenges," Trends in Genetics, vol. 30, no. 2, pp. 75-84, 2014.
132. L. Cheng and Y. Zhu, "A classification approach for DNA methylation profiling with bisulfite next-generation sequencing data," Bioinformatics, vol. 30, no. 2, pp. 172-179, 2014.
133. K. Mensaert, S. Denil, G. Trooskens, W. Van Criekinge, O. Thas, and T. De Meyer, "Next-generation technologies and data analytical approaches for epigenomics," Environmental and Molecular Mutagenesis, vol. 55, no. 3, pp. 155-170, 2014.
134. F. Allum, X. Shao, F. Guénard et al., "Characterization of functional methylomes by next-generation capture sequencing identifies novel disease-associated variants," Nature Communications, vol. 6, article 7211, 2015.
135. R.-L. Huang, F. Gu,N. B. Kirma et al., "Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers," Epigenetics, vol. 8, no. 6, pp. 624-634, 2013.
136. C. Jerónimo, P. J. Bastian, A. Bjartell et al., "Epigenetics in prostate cancer: biologic and clinical relevance," European Urology, vol. 60, no. 4, pp. 753-766, 2011.
137. J. Nakamura, T. Tanaka, Y. Kitajima, H. Noshiro, and K. Miyazaki, "Methylation-mediated gene silencing as biomarkers of gastric cancer: a review," World Journal of Gastroenterology, vol. 20, no. 34, pp. 11991-12006, 2014.
138. S. Ghosh, F. Gu, C.-M. Wang et al., "Genome-wideDNAmethylation profiling reveals parity-associated hypermethylation of FOXA1," Breast Cancer Research and Treatment, vol. 147, no. 3, pp. 653-659, 2014.
139. K. Warton, V. Lin, T. Navin et al., "Methylation-capture and next-generation sequencing of free circulating DNA from human plasma," BMC Genomics, vol. 15, article 476, 2014.
140. A. W. Walker, S. H. Duncan, P. Louis, andH. J. Flint, "Phylogeny, culturing, and metagenomics of the human gut microbiota," Trends in Microbiology, vol. 22, no. 5, pp. 267-274, 2014.
141. A. W. Janssen and S. Kersten, "The role of the gut microbiota in metabolic health," The FASEB Journal, vol. 29, no. 8, pp. 3111-3123, 2015.
142. K. Faust, L. Lahti, D. Gonze, W. M. de Vos, and J. Raes, "Metagenomicsmeets timeseries analysis: unraveling microbial community dynamics," Current Opinion in Microbiology, vol. 25, pp. 56-66, 2015.
143. I. Sekirov, S. L. Russell, L. C. M. Antunes, and B. B. Finlay, "Gut microbiota in health and disease," Physiological Reviews, vol. 90, no. 3, pp. 859-904, 2010.
144. A. D. Kostic, R. J. Xavier, and D. Gevers, "The microbiome in inflammatory bowel disease: current status and the future ahead," Gastroenterology, vol. 146, no. 6, pp. 1489-1499, 2014.
145. Y. Goto, Y. Kurashima, and H. Kiyono, "The gut microbiota and inflammatory bowel disease," Current Opinion in Rheumatology, vol. 27, no. 4, pp. 388-396, 2015.
146. A. J. Cox, N. P. West, andA. W. Cripps, "Obesity, inflammation, and the gut microbiota," The Lancet Diabetes & Endocrinology, vol. 3, no. 3, pp. 207-215, 2015.
147. C. Sanmiguel, A. Gupta, and E. A. Mayer, "Gut microbiome and obesity: a plausible explanation for obesity," CurrentObesity Reports, vol. 4, no. 2, pp. 250-261, 2015.
148. H. Yu,H. Meng, F. Zhou,X. Ni, S. Shen, andU. N. Das, "Urinary microbiota in patientswith prostate cancer and benign prostatic hyperplasia," Archives of Medical Science, vol. 11, no. 2, pp. 385-394, 2015.
149. C. Weber, "Nutrition: diet change alters microbiota and might affect cancer risk," Nature Reviews Gastroenterology & Hepatology, vol. 12, article 314, 2015.
150. V. D'Argenio and F. Salvatore, "The role of the gut microbiome in the healthy adult status," Clinica Chimica Acta, 2015.
151. C. K. Lee, C. W. Herbold, S. W. Polson et al., "Groundtruthing next-gen sequencing for microbial ecology-biases and errors in community structure estimates from PCR amplicon pyrosequencing," PLoS ONE, vol. 7, no. 9,Article ID e44224, 2012.
152. V. D'Argenio, V. Precone, G. Casaburi et al., "An altered gut microbiome profile in a child affected by Crohn's disease normalized after nutritional therapy," American Journal of Gastroenterology, vol. 108, no. 5, pp. 851-852, 2013.
153. J. K. Harris, R. Fang, B. D. Wagner et al., "Esophageal microbiome in eosinophilic esophagitis," PLoS ONE, vol. 10, no. 5, Article ID e0128346, 2015.
154. B. Coburn, P. W. Wang, J. Diaz Caballero et al., "Lung microbiota across age and disease stage in cystic fibrosis," Scientific Reports, vol. 5, Article ID 10241, 2015.
155. O. J. Park, H. Yi, J. H. Jeon et al., "Pyrosequencing analysis of subgingival microbiota in distinct periodontal conditions," Journal of Dental Research, vol. 94, no. 7, pp. 921-927, 2015.
156. J. C. Marioni, C. E. Mason, S. M. Mane, M. Stephens, and Y. Gilad, "RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays,"Genome Research, vol. 18, no. 9, pp. 1509-1517, 2008.
157. S. Zhao, W.-P. Fung-Leung, A. Bittner, K. Ngo, and X. Liu, "Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells," PLoS ONE, vol. 9, no. 1, Article ID e78644, 2014.
158. N. E. Ilott and C. P. Ponting, "Predicting long non-coding RNAs using RNA sequencing," Methods, vol. 63, no. 1, pp. 50-59, 2013.
159. M. Yang, L. Xu, Y. Liu, and P. Yang, "RNA-seq uncovers SNPs and alternative splicing events in Asian Lotus (Nelumbo nucifera)," PLoS ONE, vol. 10, no. 4, Article IDe0125702, 2015.
160. C. A. Maher, C. Kumar-Sinha, X. Cao et al., "Transcriptome sequencing to detect gene fusions in cancer," Nature, vol. 458, no. 7234, pp. 97-101, 2009.
161. GTEx Consortium, "Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans," Science, vol. 348, pp. 648-660, 2015.
162. M. Melé, P. G. Ferreira, F. Reverter et al., "Human genomics. The human transcriptome across tissues and individuals," Science, vol. 348, no. 6235, pp. 660-665, 2015.
163. F. W. Albert and L. Kruglyak, "The role of regulatory variation in complex traits and disease," Nature Reviews Genetics, vol. 16, no. 4, pp. 197-212, 2015.
164. G. R. Oliver, S. N. Hart, and E. W. Klee, "Bioinformatics for clinical next generation sequencing," Clinical Chemistry, vol. 61, no. 1, pp. 124-135, 2015.
165. A. S. Gargis, L. Kalman, D. P. Bick et al., "Good laboratory practice for clinical next-generation sequencing informatics pipelines," Nature Biotechnology, vol. 33, no. 7, pp. 689-693, 2015.
166. S. Richards, N. Aziz, S. Bale et al., "Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology," Genetics in Medicine, vol. 17, no. 5, pp. 405-424, 2015.
167. J. G. Caporaso, J. Kuczynski, J. Stombaugh et al., "QIIME allows analysis of high-throughput community sequencing data," Nature Methods, vol. 7, no. 5, pp. 335-336, 2010.
168. V. D'Argenio, G. Casaburi, V. Precone, and F. Salvatore, "Comparative metagenomic analysis of human gut microbiome composition using two different bioinformatic pipelines," BioMed Research International, vol. 2014, Article ID 325340, 10 pages, 2014.
169. B. Fosso, M. Santamaria, M. Marzano et al., "BioMaS: a modular pipeline for Bioinformatic analysis of Metagenomic AmpliconS," BMC Bioinformatics, vol. 16, article 203, 2015.
170. M. D'Antonio, P. D'Onorio De Meo, M. Pallocca et al., "RAP: RNA-Seq analysis pipeline, a new cloud-based NGS web application," BMC Genomics, vol. 16, supplement 6, article S3, 2015.
171. R. A. Calogero and F. Zolezzi, "Quantifying entire transcriptomes by aligned RNA-seq data,"Methods inMolecular Biology, vol. 1269, pp. 163-172, 2015.
172. H. L. Rehm, S. J. Bale, P. Bayrak-Toydemir et al., "ACMGclinical laboratory standards for next-generation sequencing," Genetics in Medicine, vol. 15, no. 9, pp. 733-747, 2013.
173. R. Bao, L. Huang, J. Andrade et al., "Reviewof currentmethods, applications, and data management for the bioinformatics analysis of whole exome sequencing," Cancer Informatics, vol. 13, supplement 2, pp. 67-82, 2014.
174. B. Liu, R. K. Madduri, B. Sotomayor et al., "Cloud-based bioinformatics workflow platform for large-scale next-generation sequencing analyses," Journal of Biomedical Informatics, vol. 49, pp. 119-133, 2014.
175. Y. Xue, A. Ankala, W. R. Wilcox, and M. R. Hegde, "Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: singlegene, gene panel, or exome/genome sequencing," Genetics in Medicine, vol. 17, no. 6, pp. 444-451, 2014.
176. J. A. Reuter, D. V. Spacek, and M. P. Snyder, "High-throughput sequencing technologies,"Molecular Cell, vol. 58,no. 4, pp. 586-597, 2015.
177. J. Eid, A. Fehr, J. Gray et al., "Real-time DNA sequencing from single polymerase molecules," Science, vol. 323, no. 5910, pp. 133-138, 2009.
178. E. W. Loomis, J. S. Eid, P. Peluso et al., "Sequencing the unsequenceable: expanded CGG-repeat alleles of the fragile X gene," Genome Research, vol. 23, no. 1, pp. 121-128, 2013.
179. M. J. P. Chaisson, J. Huddleston,M. Y. Dennis et al., "Resolving the complexity of the human genome using single-molecule sequencing," Nature, vol. 517, pp. 608-611, 2015.
180. M. O. Carneiro, C. Russ, M. G. Ross, S. Gabriel, C. Nusbaum, andM. A. DePristo, "Pacific biosciences sequencing technology for genotyping and variation discovery in human data," BMC Genomics, vol. 13, article 375, 2012.
181. M. Jain, I. T. Fiddes, K. H. Miga, H. E. Olsen, B. Paten, and M. Akeson, "Improved data analysis for the MinION nanopore sequencer," Nature Methods, vol. 12, pp. 351-356, 2015.
182. R. Drmanac, A. B. Sparks, M. J. Callow et al., "Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays," Science, vol. 327, no. 5961, pp. 78-81, 2010